Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between GCM Securities IPO and HPC Biosciences IPO.
GCM Securities IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while HPC Biosciences IPO is a SME Fixed Price Issue proposed to list at BSE SME.
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt Ltd | Guiness Corporate Advisors Pvt Ltd |
| Registrar | Purva Sharegistry India Pvt Ltd | Cameo Corporate Services Limited |
| Market Maker | ||
| DRHP | DRHP  |
|
| RHP | RHP |
|
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of GCM Securities IPO is up to ₹12.18 Cr whereas the issue size of the HPC Biosciences IPO is up to ₹15.75 Cr. The final issue price of GCM Securities IPO is ₹20.00 per share and of HPC Biosciences IPO is ₹35.00 per share.
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹20.00 per share | ₹35.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 6000 shares | 4000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 60,90,000 shares | 45,00,000 shares |
| Issue Size Total (Amount) | up to ₹12.18 Cr | up to ₹15.75 Cr |
GCM Securities IPO opens on Mar 18, 2013, while HPC Biosciences IPO opens on Mar 01, 2013. The closing date of GCM Securities IPO and HPC Biosciences IPO is Mar 20, 2013, and Mar 05, 2013, respectively.
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 18, 2013 | Mar 01, 2013 |
| Issue Close | Mar 20, 2013 | Mar 05, 2013 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
GCM Securities IPO P/E ratio is , as compared to HPC Biosciences IPO P/E ratio of .
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the GCM Securities IPO retail investors (RII) are offered while in HPC Biosciences IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in GCM Securities IPO and in HPC Biosciences IPO.
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
GCM Securities IPO subscribed in total, whereas HPC Biosciences IPO subscribed .
| GCM Securities IPO | HPC Biosciences IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
